A5055284771- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Biomedical Ethics and Regulation
- Blood Pressure and Hypertension Studies
- Pharmaceutical industry and healthcare
- Economic and Financial Impacts of Cancer
- Cardiac, Anesthesia and Surgical Outcomes
- Pluripotent Stem Cells Research
- Pharmaceutical studies and practices
- Emergency and Acute Care Studies
- Biomedical and Chemical Research
- Dental Anxiety and Anesthesia Techniques
- Pharmaceutical Practices and Patient Outcomes
- Health, Medicine and Society
- Healthcare Systems and Practices
- Science, Research, and Medicine
- Nosocomial Infections in ICU
- Clostridium difficile and Clostridium perfringens research
- Patient Safety and Medication Errors
- Statistical Methods in Clinical Trials
- Cardiac Health and Mental Health
- European Cultural and National Identity
- CAR-T cell therapy research
- Sodium Intake and Health
- Public Health in Brazil
Vilnius University
2006-2022
Payers are a major stakeholder in any considerations and initiatives concerning adaptive licensing of new medicinal products, also referred to as Medicines Adaptive Pathways patients (MAPPs). Firstly, the scope necessity MAPPs need further scrutiny, especially with regard definition unmet need. Conditional approval pathways already exist for medicines seriously debilitating or life-threatening diseases only limited number innovative. will result initially evidence about their effectiveness...
The 3-day course on the managed introduction of new drugs was organised by Piperska group together with Agency for Health Technology Assessment and Tariff System (AOTMiT) WHO Europe to share experiences case histories among health authority insurance company personnel, academics those from commercial organisations across potential ways optimise entry medicines.This starts pre-launch horizon scanning budgeting, then peri-launch including critical drug evaluation, finally post launch...
Abstract Background The reimbursement of orphan drugs (OD) is an increasingly important for country policymakers, and still insufficiently understood, especially in Central Eastern Europe. aim this research was to provide a comprehensive description country-specific health technology assessment (HTA) policies as well evaluate the percentage HTA recommendations decisions oncology OD. In addition, study designed elucidate impact these on public budget agreement between analysed countries. A...
The aim of this ecological study was to evaluate whether any changes in cardiovascular (CV) medicine utilization, population, socioeconomic and health system factors were associated with CV mortality Lithuania, Sweden Norway 2003–2012. drug utilization calculated using the Anatomical Therapeutic Chemical/Defined Daily Dose (DDD) methodology expressed as a number DDD per 1000 inhabitants day (DDD/TID). age-standardized death rate (CV-SDR) risk data obtained from WHO, EUROSTAT, FAOSTAT...
Background. Despite the wide use of cardiovascular (CV) drugs, CV diseases are still leading cause mortality and morbidity. Analysis drug utilization gives a possibility to evaluate effectiveness interventions. Materials methods. The aim study was medicines consumption in Lithuania 2003–2012. Data retrieved from SVEIDRA database National Health Insurance Fund. Utilization following groups CVM (ATC group C) analyzed: C02 – antihypertensive C03 diuretics, C07 beta blocking agents (BBs), C08...
High blood pressure is a major risk factor contributing to death and disability rates in the Baltic states. The aim of this study was compare utilization antihypertensive medicines Estonia, Latvia Lithuania from 2008 2018. In retrospective cross-national comparison, nationally representative wholesale data IQVIA National Retail Audit were analyzed. inhibitors renin–angiotensin system, beta blockers, calcium channel diuretics centrally acting antihypertensives by Defined Daily Doses per 1000...
La surveillance des infections nosocomiales est un parametre de bonnes pratiques cliniques souvent neglige dans les etablissements soins, en raison la charge travail qu’elle implique l’absence systemes informatiques adequats. L’objectif
La vigilancia de las infecciones nosocomiales es un parametro buenas practicas clinicas demasiado descuidado en instituciones sanitarias, debido al trabajo que implica cuando no existe sistema informatico adecuado. El objetivo este estudio fue evaluar si se podia utilizar protocolo sencillo para estimar la carga y dicho pudiera ser base a largo plazo. Esa evaluacion llevo cabo tres centros hospitalarios universitarios, Huddinge Suecia, Riga Letonia Vilnius Lituania. Se analizaron los...